CELC vs CLYM: fair value comparison
Celcuity Inc. and Climb Bio, Inc. · Updated 2026-10-19
CELC has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. CLYM has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, CELC currently ranks higher by quality score.
| CELC | CLYM | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $56.58 | $9.82 |
| 12-month range | $56.58–$144.98 | $1.64–$17.84 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #227 of 301 Healthcare | #229 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Low |
| RSI zone | Oversold | Oversold |
| 50/200-day trend | Downtrend | Mixed |
| 52-week position | The bottom quarter | The upper-middle quarter |
Full single-stock breakdowns: CELC fair value analysis · CLYM fair value analysis